,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast']
while the west is rejoicing with the results of destiny breast 04 trial &amp; the plenary session at #asco22, i am wondering if it will go beyond theoretical knowledge in this part of the world.. "close the care gap" is such a reality
Additional Professor of Surgery (breast-endo surgery as surgical forte), AIIMS New Delhi. Tweets in personal capacity, RT# endorsement, Nation first